Hints and tips:
Related Special Reports
...Roche’s chief executive Thomas Schinecker said: “Obesity is a heterogeneous disease, which contributes to many other diseases that together comprise a significant health burden worldwide....
...Documents published on Monday showed that Wolf would step down following Vitesco’s merger with Schaeffler, with Thomas Stierle — Vitesco’s head of electrification solutions — taking over as head of what...
...Daniel Thomas 8....
...Qatalyst Partners was the lead financial adviser to Thoma Bravo. Goldman Sachs was the lead financial adviser to Nasdaq....
...Nasdaq will buy Adenza from investment company Thoma Bravo....
...But Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers and Associations, said governments had gone from appreciating rapid innovation during the pandemic, to needing...
...The Roche setback adds to the list of challenges facing chief executive-designate Thomas Schinecker when he takes over next year....
...April 9; further information and tickets here ‘Dior habille les nuits’ (Dior Dresses the Night), Palais des Congrès Giorgio Mancini’s Nuit Dansée and Angelin Prejlocaj’s Nuit Romaine will be danced by...
...Schwan will be succeeded by Thomas Schinecker, head of the diagnostics unit....
..., Hannah Kuchler, Siddharth Venkataramakrishnan, Kate Beioley, Emma Dunkley, Donato Paolo Mancini, Tom Wilson and Pilita Clark...
...Pharma giant Roche’s chief executive Severin Schwan is to step down next March and be succeeded by Thomas Schinecker, the head of the diagnostics unit, the company said on Thursday....
...“Pfizer’s investment in Valneva highlights the quality of the work that we’ve done together over the past two years and is a strong recognition of Valneva’s vaccine expertise,” Valneva chief executive Thomas...
...Thomas Breuer, GSK’s chief global health officer, said the results were “encouraging”....
...Thomas Lingelbach, Valneva chief executive, said the company was grateful to the commission for its support....
...Thomas Breuer, the company’s chief global health officer, said the move would “reinvigorate the fight against malaria in the region at a time when progress on malaria control has stalled”....
Regulator Ofgem says 11m households will approach a peak hit in 2013
...Thomas Lingelbach, Valneva’s chief executive, pointed out a flaw in the Cov-Boost trial, saying it boosts “very early”, after two-and-a-half to three months....
...Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers & Associations, says it is up to governments with surplus doses like the US, UK, EU and Canada to make sure...
...Thomas Lingelbach, Valneva chief executive, said it was aiming to produce 150m to 200m doses a year. “Of course we are not going to be the ones to produce billions of doses....
...lack of a sustainable market where investments in antibiotics research and development get a fair return, by getting a proper valuation of new antibiotics, our society and our economies will suffer,” says Thomas...
...Samuel Alito and Clarence Thomas are both hardline opponents of the right to choose....
...Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers and Associations, a lobby group, argued that transparency was vital for clinical trials but that releasing confidential...
Move follows a sharp decline in wholesale gas and electricity prices due to pandemic
...“If you look at the curves going up everywhere, relying on PCR alone will not work,” Thomas Schinecker, head of diagnostics at the Swiss company, told the Financial Times....
International Edition